Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Purpose: Von Hippel-Lindau (VHL) disease is an autosomal-dominantly inherited tumor predisposition syndrome. One of the most common tumors are central nervous system (CNS) hemangioblastomas. Recommendations on the initiation and continuation of the screening and surveillance program for CNS tumors in pediatric VHL patients are based on small case series and thus low evidence level. To derive more robust screening recommendations, we report on the largest monocentric pediatric cohort of VHL patients. Methods: We performed a retrospective analysis on a pediatric cohort of 99 VHL patients consulted at our VHL center from 1992 to 2023. Clinical, surgical, genetic, and imaging data were collected and statistically analyzed. Results: 42 patients (50% male) developed CNS hemangioblastomas, of whom 18 patients (56% male) underwent hemangioblastoma surgery (mean age at first surgery: 14.9 ± 1.9 years; range 10.2–17). The first asymptomatic patient was operated on at the age of 13.2 years due to tumor progress. Truncating VHL mutation carriers had a significantly higher manifestation rate (HR = 3.7, 95% CI: 1.9–7.4, p < 0.0001) and surgery rate (HR = 3.3, 95% CI: 1.2–8.9, p = 0.02) compared with missense mutation carriers. Conclusion: We recommend starting MRI imaging at the age of 12 years with examination intervals every (1-) 2 years depending on CNS involvement. Special attention should be paid to patients with truncating variants. Affected families should be educated regularly on potential tumor-associated symptoms to enable timely MRI imaging and eventually intervention, as CNS hemangioblastoma may develop before screening begins. German clinical trials Register registration number: DRKS00029553, date of registration 08/16/2022, retrospectively registered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
Cited by 8
Research works printed but not linked: 30
- Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (1990) Clinical features and natural history of Von Hippel-Lindau disease. Q J Med 77(283):1151–1163. https://doi.org/10.1093/qjmed/77.2.1151 · DOI · Paper page
- Maher ER, Neumann HP, Richard S (2011) Von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 19(6):617–623. https://doi.org/10.1038/ejhg.2010.175 · DOI · Paper page
- Lonser RR, Glenn G, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003) Von Hippel-Lindau disease. Lancet 361(9374):2059–2067. https://doi.org/10.1016/S0140-6736(03)13643-4 · DOI · Paper page
- Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L (1993) Identification of the Von Hippel-Lindau disease tumor suppressor gene. Science 260(5112):1317–1320. https://doi.org/10.1126/science.8493574 · DOI · Paper page
- Binderup ML, Budtz-Jorgensen E, Bisgaard ML (2016) Risk of new tumors in Von Hippel-Lindau patients depends on age and genotype. Genet Med 18(1):89–97. https://doi.org/10.1038/gim.2015.44 · DOI
- The VHL, Alliance (2020) The VHL Handbook 6. Edition
- Feletti A, Anglani M, Scarpa B, Schiavi F, Boaretto F, Zovato S, Taschin E, Gardi M, Zanoletti E, Piermarocchi S, Murgia A, Pavesi G, Opocher G (2016) Von Hippel-Lindau disease: an evaluation of natural history and functional disability. Neuro Oncol 18(7):1011–1020. https://doi.org/10.1093/neuonc/nov313 · DOI
- Wang Q, Meng S, Cheng J, Zhang S, Ju Y, Fang Y, Zhang Y, Huang S, Liu W, Hui X (2020) Central nervous system hemangioblastomas: an age-stratified analysis. Clin Neurol Neurosurg 199:106281. https://doi.org/10.1016/j.clineuro.2020.106281 · doi:10.1016/j.clineuro.2020.106281
- Klingler JH, Gläsker S, Bausch B, Urbach H, Krauss T, Jilg CA, Steiert C, Puzik A, Neumann-Haefelin E, Kotsis F, Agostini H, Neumann HPH, Beck J (2020) Hemangioblastoma and Von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment. Childs Nerv Syst 36(10):2537–2552. https://doi.org/10.1007/s00381-020-04712-5 · doi:10.1007/s00381-020-04712-5
- Launbjerg K, Bache I, Galanakis M, Bisgaard ML, Binderup MLM (2017) Von Hippel-Lindau development in children and adolescents. Am J Med Genet A 173(9):2381–2394. https://doi.org/10.1002/ajmg.a.38324 · doi:10.1002/ajmg.a.38324
- Lonser RR, Butman JA, Huntoon K, Asthagiri AR, Wu T, Bakhtian KD, Chew EY, Zhuang Z, Linehan WM, Oldfield EH (2014) Prospective natural history study of central nervous system hemangioblastomas in Von Hippel-Lindau disease. J Neurosurg 120(5):1055–1062. https://doi.org/10.3171/2014.1.JNS131431 · DOI · Paper page
- Dornbos D 3rd, Kim HJ, Butman JA, Lonser RR (2018) Review of the neurological implications of Von Hippel-Lindau Disease. JAMA Neurol 75(5):620–627. https://doi.org/10.1001/jamaneurol.2017.4469 · DOI
- Ammerman JM, Lonser RR, Dambrosia J, Butman JA, Oldfield EH (2006) Long-term natural history of hemangioblastomas in patients with Von Hippel-Lindau disease: implications for treatment. J Neurosurg 105(2):248–255. https://doi.org/10.3171/jns.2006.105.2.248 · DOI · Paper page
- Louise M, Binderup M, Smerdel M, Borgwadt L et al (2022) Von Hippel-Lindau disease: updated guideline for diagnosis and surveillance. Eur J Med Genet 65(8):104538. https://doi.org/10.1016/j.ejmg.2022.104538 · DOI · Paper page
- Huntoon K, Shepard MJ, Lukas RV, McCutcheon IE, Daniels AB, Asthagiri AR (2021) Hemangioblastoma diagnosis and surveillance in Von Hippel-Lindau disease: a consensus statement. J Neurosurg 136(6):1511–1516. https://doi.org/10.3171/2021.3.JNS204203 · doi:10.3171/2021.3.jns204203
- Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman JD (2017) Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: clinical features, Genetics, and Surveillance recommendations in Childhood. Clin Cancer Res 23(12):e68–e75. https://doi.org/10.1158/1078-0432.CCR-17-0547 · DOI · Paper page
- Hes FJ, van der Luijt RB, Lips CJ (2001) Clinical management of Von Hippel-Lindau (VHL) disease. Neth J Med 59(5):225–234. https://doi.org/10.1016/s0300-2977(01)00165-6 · DOI
- Kruizinga RC, Sluiter WJ, de Vries EG, Zonnenberg BA, Lips CJ, van der Horst-Schrivers AN, Walenkamp AM, Links TP (2013) Calculating optimal surveillance for detection of Von Hippel-Lindau-related manifestations. Endocr Relat Cancer 21(1):63–71. https://doi.org/10.1530/ERC-13-0308 · DOI
- Nordstrom-O’Brien M, van der Luijt RB, van Rooijen E, an, den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH (2010) Genetic analysis of von Hippel-Lindau disease. Human mutation 31(5):521–537. https://doi.org/10.1002/humu.21219 · DOI · Paper page
- Lundin P, Pedersen F (1992) Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 16(4):519–528. https://doi.org/10.1097/00004728-199207000-00004 · DOI · Paper page
- Han B, Zhang L, Jia W (2023) Pediatric spinal hemangioblastomas: clinical features and Surgical outcomes of 39 cases. Neurospine 20(1):343–352. https://doi.org/10.14245/ns.2244970.485 · doi:10.14245/ns.2244970.485
- Salama Y, Albanyan S, Szybowska M et al (2019) Comprehensive characterization of a Canadian cohort of Von Hippel-Lindau disease patients. Clin Genet 96(5):461–467. https://doi.org/10.1111/cge.13613 · DOI
- Wang JY, Peng SH, Ning XH, Li T, Liu SJ, Liu JY, Hong BA, Qi NN, Peng X, Zhou BW, Zhang JF, Cai L, Gong K (2017) Shorter telomere length increases age-related tumor risks in Von Hippel-Lindau disease patients. Cancer Med 6(9):2131–2141. https://doi.org/10.1002/cam4.1134 · DOI
- Binderup ML, Budtz-Jørgensen E, Bisgaard ML (2015) New Von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy. Neurology 85(17):1500–1503. https://doi.org/10.1212/WNL.0000000000002064 · doi:10.1212/wnl.0000000000002064
- Wanebo JE, Lonser RR, Glenn GM, Oldfield EH (2003) The natural history of hemangioblastomas of the central nervous system in patients with Von Hippel-Lindau disease. J Neurosurg 98(1):82–94. https://doi.org/10.3171/jns.2003.98.1.0082 · DOI · Paper page
- Cheng J, Liu W, Hui X, Zhang S, Ju Y (2017) Pediatric central nervous system hemangioblastomas: different from adult forms? A retrospective series of 25 cases. Acta Neurochir (Wien) 159(9):1603–1611. https://doi.org/10.1007/s00701-017-3275-0 · doi:10.1007/s00701-017-3275-0
- Vougioukas VI, Gläsker S, Hubbe U, Berlis A, Omran H, Neumann HP, Van Velthoven V (2006) Surgical treatment of hemangioblastomas of the central nervous system in pediatric patients. Childs Nerv Syst 22(9):1149–1153. https://doi.org/10.1007/s00381-005-0018-y · doi:10.1007/s00381-005-0018-y
- Huntoon K, Wu T, Elder JB, Butman JA, Chew EY, Linehan WM, Oldfield EH, Lonser RR (2016) Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in Von Hippel-Lindau disease. J Neurosurg 124(4):971–976. https://doi.org/10.3171/2015.4.JNS1533 · doi:10.3171/2015.4.jns1533
- Poulsen ML, Budtz-Jørgensen E, Bisgaard ML (2010) Surveillance in Von Hippel-Lindau disease (vHL). Clin Genet 77(1):49–59. https://doi.org/10.1111/j.1399-0004.2009.01281.x · doi:10.1111/j.1399-0004.2009.01281.x
- Neumann HP, Cybulla M, Gläsker S et al (2007) Von-Hippel-Lindau-Erkrankung. Interdisziplinäre Patientenversorgung [Von Hippel-Lindau disease. Interdisciplinary patient care]. Spektrum Augenheilkd 21(5):271–278. https://doi.org/10.1007/s00717-007-0222-0 · doi:10.1007/s00717-007-0222-0
Metadata
- Authors
- Knoblauch, A. L., Blaß, B.-I., Steiert, C., Neidert, N., Puzik, A., Neumann-Haefelin, E., Ganner, A., Kotsis, F., Schäfer, T., Neumann, H. P. H., Elsheikh, S., Beck, J., & Klingler, J.-H.
- Venue
- Journal of Neuro-Oncology
- Published
- 2024-04-22
- Volume
- 168
- Issue
- 3
- Pages
- 537-545
- ISSN
- 0167-594X
- 1573-7373
- Cited by
- 8
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Universitätsklinikum Freiburg
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease. https://app.cochat.ai/papers/10.1007/s11060-024-04676-5
- The paper
- Knoblauch, A. L., Blaß, B.-I., Steiert, C., Neidert, N., Puzik, A., Neumann-Haefelin, E., Ganner, A., Kotsis, F., Schäfer, T., Neumann, H. P. H., Elsheikh, S., Beck, J., & Klingler, J.-H. (2024). Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04676-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.